Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

1.5K
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.5K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

721
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
721
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

640
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
640
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

805
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
805
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

611
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
611
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.5K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative performance of wearable ECG devices for rhythm monitoring in endurance athletes.

American journal of preventive cardiology·2026
Same author

Physiological responses during a maximal dry static breath-hold in a world champion freediver.

Respiratory physiology & neurobiology·2026
Same author

An AV-Synchronous Leadless Pacemaker with Electrical Far-Field Atrial Sensing in a Sheep Model.

Heart rhythm·2026
Same author

Association of self-reported sports volume and discipline with atrial arrhythmia prevalence in middle-aged males.

European heart journal open·2026
Same author

High frame rate speckle tracking echocardiography to image the left ventricular mechanical activation sequence in healthy participants and patients with left bundle branch block.

European heart journal. Imaging methods and practice·2026
Same author

Mechanical resynchronization in left bundle branch block achieved by conduction system pacing: A strain-based analysis.

Heart rhythm·2026

Related Experiment Video

Updated: Apr 18, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

11.1K

How to choose between a pacemaker or defibrillator for resynchronization therapy?

Carl Gillebert, Thomas Marynissen, Roel Janssen

    Acta Cardiologica
    |February 3, 2015
    PubMed
    Summary

    The study found that while cardiac resynchronization therapy with a defibrillator (CRT-D) showed lower mortality in simple analyses, this survival benefit for CRT-D versus CRT-P diminished in complex models, suggesting it is marginal.

    More Related Videos

    Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
    10:17

    Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

    Published on: April 11, 2025

    2.3K
    A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
    16:40

    A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

    Published on: February 28, 2012

    27.0K

    Related Experiment Videos

    Last Updated: Apr 18, 2026

    Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
    12:45

    Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

    Published on: December 11, 2017

    11.1K
    Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
    10:17

    Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

    Published on: April 11, 2025

    2.3K
    A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
    16:40

    A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

    Published on: February 28, 2012

    27.0K

    Area of Science:

    • Cardiology
    • Medical Devices
    • Clinical Outcomes

    Background:

    • Cardiac resynchronization therapy (CRT) is used for heart failure management.
    • The choice between CRT with a defibrillator (CRT-D) and CRT with a pacemaker (CRT-P) remains debated.
    • ESC guidelines suggest patient selection based on comorbidities and age.

    Purpose of the Study:

    • To investigate if CRT-D offers a long-term survival benefit over CRT-P when patients are selected according to ESC guidelines.
    • To evaluate the impact of comorbidities and age on the survival outcomes of CRT-P versus CRT-D.

    Main Methods:

    • Retrospective analysis of 144 patients who received CRT devices between 2001 and 2007.
    • Uni- and multivariate Cox regression analyses were performed to assess predictors of outcome.
    • Three distinct multivariate models were applied to analyze survival differences.

    Main Results:

    • Patients receiving CRT-P were older with more comorbidities.
    • CRT-D recipients initially showed significantly lower mortality.
    • Multivariable analyses indicated that the survival benefit of CRT-D over CRT-P disappeared with increasing model complexity.
    • Amiodarone use and COPD/renal insufficiency were associated with higher mortality; beta-blockers were protective.

    Conclusions:

    • The apparent survival benefit of CRT-D over CRT-P was dependent on the number of covariates in the analysis.
    • The survival advantage of CRT-D, if present, is likely marginal when accounting for patient characteristics.
    • Comorbidities like COPD and renal insufficiency significantly impact mortality risk in CRT patients.